Form 8-K

8-K — Health In Tech, Inc.

Accession: 0001213900-26-035500

Filed: 2026-03-27

Period: 2026-03-27

CIK: 0002019505

SIC: 6411 (INSURANCE AGENTS BROKERS & SERVICES)

Item: Entry into a Material Definitive Agreement

Item: Financial Statements and Exhibits

Documents

8-K — ea0283796-8k_health.htm (Primary)

EX-99.1 — PRESS RELEASE DATED MARCH 27, 2026 (ea028379601ex99-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0283796-8k_health.htm · Sequence: 1

false

0002019505

2026-03-27

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 OR 15(d) of The Securities

Exchange Act of 1934

March 27, 2026

Date of Report (Date of earliest event reported)

Health In Tech, Inc.

(Exact name of registrant as specified in its charter)

Nevada

001-42449

87-3545722

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

701 S. Colorado Ave, Suite 1

Stuart, FL

34994

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including

area code: (888) 373-0333

N/A

(Former name or former address, if changed since

last report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b)

of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Class A Common Stock, $0.001 par value per share

HIT

The Nasdaq Stock Market LLC

(Nasdaq Capital Market)

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities

Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item

1.01 Entry into a Material Definitive Agreement.

On March 27, 2026, Health In Tech, Inc., a Nevada

corporation (the “Company”), issued a press release announcing the closing of its previously announced private investment

in public equity financing, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference herein. The information

furnished in Exhibit 99.1 hereto shall not be considered “filed” for purposes of Section 18 of the Securities Exchange Act

of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be incorporated

by reference into future filings by the Company under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company

expressly sets forth in such future filings that such information is to be considered “filed” or incorporated by reference

therein.

Forward-Looking Statements

Certain statements in this Current Report on Form

8-K or in the accompanying exhibits are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities

Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech’s possible

or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry

environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,”

“will,” “should,” “design,” “target,” “aim,” “hope,” “expect,”

“could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,”

“continue,” “predict,” “project,” “potential,” “goal,” or other words that

convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech’s future financial

performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech’s actual results,

levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements

expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they

involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech’s control and which

could, and likely will, affect actual results, levels of activity, performance or achievements. Some of the risks and uncertainties, although

not all risks and uncertainties, that could cause the Company’s actual results to differ materially from those presented in its

forward-looking statements are set forth in the “Risk Factors” section in the Company’s Annual Report on Form 10-K,

its Quarterly Reports on Form 10-Q, and all of its other filings with the SEC, as such risks, uncertainties and other important factors

may be updated from time to time in the Company’s subsequent reports. Any forward-looking statement reflects Health In Tech’s

current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health

In Tech’s operations, results of operations, growth strategy and liquidity. Health In Tech undertakes no obligation to update any

forward-looking statements, except as required by law.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits:

Exhibit No.

Description

99.1

Press release dated March 27, 2026.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities

Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: March 27, 2026

HEALTH IN TECH, INC.

By:

/s/ Tim Johnson

Name:

Tim Johnson

Title:

Chief Executive Officer

EX-99.1 — PRESS RELEASE DATED MARCH 27, 2026

EX-99.1

Filename: ea028379601ex99-1.htm · Sequence: 2

Exhibit 99.1

Health In Tech Announces Closing of $7.0 Million Private Placement

Stuart, FL., March 27, 2026 /PRNewswire/ — Health In Tech, Inc.

(Nasdaq: HIT) (“Health In Tech” or the “Company”), an AI-enabled InsurTech platform company, today announced the closing

of its previously announced private investment in public equity financing (the “PIPE”), resulting in gross proceeds of approximately

$7.0 million before deducting placement agent fees and offering expenses.

The PIPE included participation from institutional investors and accredited

investors. The Company issued an aggregate of 5,600,000 shares of common stock at a price of $1.25 per share.

Craig-Hallum Capital Group LLC acted as the sole placement agent for

the PIPE. Loeb & Loeb LLP acted as counsel to the Company. Faegre Drinker Biddle & Reath LLP acted as counsel to the placement

agent.

Strengthening Financial Flexibility to Support Strategic Growth

“This financing strengthens our ability to accelerate the next

phase of our platform development,” said Tim Johnson, Chief Executive Officer of Health In Tech. “The additional capital will

support key technology initiatives and help us bring new product capabilities to market that our clients have been actively requesting.

As we continue expanding the functionality of our platform, we believe it will deepen customer engagement and support sustained, scalable

revenue growth.”

Use of Proceeds

The Company intends to use the net proceeds from the private placement

for:

● Expansion of sales distribution

● Advance technology development

● Support new product development

● General corporate purposes and working capital

“In addition, the transaction introduces new long-term institutional

investors to our shareholder base,” said Julia Qian, Chief Financial Officer of Health In Tech. “We believe this will enhance

market visibility and support our broader capital markets strategy while providing flexibility to continue investing in our technology

and growth initiatives.”

The securities described above are being offered in a private placement

under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and/or Regulation D promulgated thereunder,

and have not been registered under the Securities Act or applicable state securities laws. Accordingly, the securities issued in the PIPE

may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from

the registration requirements of the Securities Act and such applicable state securities laws. Pursuant to a registration rights agreement

with the PIPE investors, the Company has agreed to file a resale registration statement with the Securities and Exchange Commission registering

the resale of the shares of Class A common stock described above.

Use of Forward-Looking Statements

Certain statements in this press release are forward-looking statements

for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements

may include estimates or expectations about Health In Tech’s possible or assumed operational results, financial condition, business strategies

and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking

statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,”

“aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,”

“estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,”

or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech’s

future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech’s actual

results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or

achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements

because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech’s control

and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement

reflects Health In Tech’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions

relating to Health In Tech’s operations, results of operations, growth strategy and liquidity. Health In Tech undertakes no obligation

to update any forward-looking statements, except as required by law.

About Health In Tech

Health In Tech, Inc. (Nasdaq: “HIT”)

is an AI-enabled InsurTech platform company, which offers a marketplace that improves processes in the health insurance industry through

vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales

and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs) and third-party administrators (“TPAs”).

Health In Tech’s platform serves as a marketplace for brokers, TPAs, MGUs and carriers to access self-funded health insurance for employers,

providing functions including customized self-funded health plans, bindable stop-loss quotes, AI-enabled underwriting, claims administration

and reporting integration.

Investor Contact:

Health In Tech Investor Relations

ir@healthintech.com

The Equity Group

Kalle Ahl, CFA

T: (303) 953-9878

kahl@theequitygroup.com

Devin Sullivan, Managing Director

dsullivan@theequitygroup.com

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.1

Cover

Mar. 27, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Mar. 27, 2026

Entity File Number

001-42449

Entity Registrant Name

Health In Tech, Inc.

Entity Central Index Key

0002019505

Entity Tax Identification Number

87-3545722

Entity Incorporation, State or Country Code

Entity Address, Address Line One

701 S. Colorado Ave

Entity Address, Address Line Two

Suite 1

Entity Address, City or Town

Stuart

Entity Address, State or Province

Entity Address, Postal Zip Code

34994

City Area Code

888

Local Phone Number

373-0333

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Class A Common Stock, $0.001 par value per share

Trading Symbol

HIT

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration